Get startedLog in
    Picture of Chandra Bhagat Pharma logo

    542934 — Chandra Bhagat Pharma Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Chandra Bhagat Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    2026
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue9411,1972,2148671,163
    Cost of Revenue
    Gross Profit127131133134227
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses9151,1662,2918911,135
    Operating Profit25.530.6-76.8-23.827.5
    Total Net Non Operating Interest Income / Expense
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes1111.622.611.741
    Provision for Income Taxes
    Net Income After Taxes7.979.0515.38.5830.5
    Net Income Before Extraordinary Items
    Net Income7.979.0515.38.5830.5
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income7.979.0515.38.5830.5
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS1.141.292.11.144.04